Clinical Trial Update: Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and efficacy of H-1337 in subjects with primary open-angle glaucoma or ocular hypertension has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• H-1337

Snippet

Sponsor: D. Western Therapeutics Institute, Inc. | Conditions: Glaucoma Open-Angle Primary, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2025-08-27